Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMID 2480643)

Published in Science on December 22, 1989

Authors

M Huang1, C Simard, P Jolicoeur

Author Affiliations

1: Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Quebec, Canada.

Articles citing this

Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J Virol (1991) 1.70

Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. J Virol (1991) 1.50

The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J Virol (1991) 1.41

Evi-2, a common integration site involved in murine myeloid leukemogenesis. Mol Cell Biol (1990) 1.29

Characterization of the gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome. J Virol (1990) 1.20

CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med (1992) 1.20

Expression of defective virus and cytokine genes in murine AIDS. J Virol (1991) 1.12

Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence. J Virol (1992) 1.10

Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J Virol (1993) 1.09

The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus. J Virol (1993) 1.04

Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J Virol (1996) 1.00

Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells. J Virol (1994) 0.98

Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus. J Virol (1992) 0.97

A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice. Retrovirology (2012) 0.96

Delayed progression of a murine retrovirus-induced acquired immunodeficiency syndrome in X-linked immunodeficient mice. J Exp Med (1993) 0.95

Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus. J Virol (1992) 0.95

Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency. J Virol (2001) 0.93

Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation. J Virol (2004) 0.91

Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus. J Virol (1997) 0.91

Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs. J Virol (1994) 0.89

The programmed death-1 and interleukin-10 pathways play a down-modulatory role in LP-BM5 retrovirus-induced murine immunodeficiency syndrome. J Virol (2007) 0.88

High frequency of transmission of murine AIDS virus in C57BL/10 mice via mother's milk. J Virol (1992) 0.87

Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency. J Virol (1993) 0.87

The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules. J Virol (2002) 0.87

Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency. J Virol (2012) 0.87

Control of immunodeficiency and lymphoproliferation in mouse AIDS: studies of mice deficient in CD8+ T cells or perforin. J Virol (1997) 0.87

Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency sydrome development. Immunology (1999) 0.85

Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice. J Virol (1995) 0.85

In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. J Virol (1994) 0.85

Prognostic value of phenotypic alterations in blood lymphocyte subsets in a murine retrovirus-induced immunodeficiency syndrome (MAIDS). Clin Exp Immunol (1993) 0.85

CD28-B7 costimulatory blockade by CTLA4Ig delays the development of retrovirus-induced murine AIDS. J Virol (1998) 0.85

Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J Virol (1995) 0.84

Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies. J Clin Invest (1990) 0.84

CD40-associated TRAF 6 signaling is required for disease induction in a retrovirus-induced murine immunodeficiency. J Virol (2004) 0.83

Role of a cytotoxic-T-lymphocyte epitope-defined, alternative gag open reading frame in the pathogenesis of a murine retrovirus-induced immunodeficiency syndrome. J Virol (2005) 0.82

The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells. J Virol (1995) 0.82

Induction of B-cell lymphoma in BALB/c nude mice with an ecotropic, B-tropic helper virus present in the murine AIDS virus stock. J Virol (1999) 0.81

Mutational analysis of the murine AIDS-defective viral genome reveals a high reversion rate in vivo and a requirement for an intact Pr60gag protein for efficient induction of disease. J Virol (1995) 0.81

Evidence that the murine AIDS defective virus does not encode a superantigen. J Virol (1996) 0.81

Cytolytic T lymphocytes specific for tumors and infected cells from mice with a retrovirus-induced immunodeficiency syndrome. J Virol (1992) 0.80

Adoptive transfer of polyclonal and cloned cytolytic T lymphocytes (CTL) specific for mouse AIDS-associated tumors is effective in preserving CTL responses: a measure of protection against LP-BM5 retrovirus-induced immunodeficiency. J Virol (1994) 0.78

The significance of the pre-challenge immune status of mice for development of retrovirus-induced immunodeficiency syndrome (MAIDS). Clin Exp Immunol (1994) 0.75

Apoptosis by CD95 (Fas)-dependent and -independent mechanisms in Peyer's patch lymphocytes in murine retrovirus-induced immunodeficiency syndrome. J Virol (1996) 0.75

Articles by these authors

Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc Natl Acad Sci U S A (1983) 4.29

Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. J Virol (1980) 3.54

The Fv-1 gene of the mouse and its control of murine leukemia virus replication. Curr Top Microbiol Immunol (1979) 3.45

Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A (2008) 3.27

Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell (1998) 3.22

Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses. J Virol (1983) 3.07

Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature (1989) 2.91

The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J Virol (1984) 2.77

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell (1989) 2.74

Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. Proc Natl Acad Sci U S A (1976) 2.71

Variants of N-tropic leukemia virus derived from BALB/c mice. J Virol (1975) 2.50

Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus. Virology (1981) 2.37

Effect of the Fv-1 locus on the titration of murine leukemia viruses. J Virol (1975) 2.36

Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses. J Virol (1984) 2.27

Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes Dev (1996) 2.18

Involvement of Notch1 in the development of mouse mammary tumors. Oncogene (1999) 1.99

Rearrangement of a DNA sequence homologous to a cell-virus junction fragment in several Moloney murine leukemia virus-induced rat thymomas. Proc Natl Acad Sci U S A (1984) 1.93

The high leukemogenic potential of Gross passage A murine leukemia virus maps in the region of the genome corresponding to the long terminal repeat and to the 3' end of env. J Virol (1983) 1.92

Molecular cloning of infectious viral DNA from ecotropic neurotropic wild mouse retrovirus. J Virol (1983) 1.91

Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene. Proc Natl Acad Sci U S A (1989) 1.85

Cas-Br-E murine leukemia virus: sequencing of the paralytogenic region of its genome and derivation of specific probes to study its origin and the structure of its recombinant genomes in leukemic tissues. J Virol (1986) 1.83

Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic retrovirus. J Virol (1984) 1.82

Prevention of breast tumour development in vivo by downregulation of the p185neu receptor. Nat Med (1995) 1.81

Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc (1998) 1.77

New class of leukemogenic ecotropic recombinant murine leukemia virus isolated from radiation-induced thymomas of C57BL/6 mice. J Virol (1983) 1.71

Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas. Mol Cell Biol (1986) 1.70

Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med (1996) 1.67

Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1996) 1.63

Development of sleep patterns in early adolescence. J Sleep Res (2001) 1.61

Pictures and names: making the connection. Cogn Psychol (1984) 1.61

Restriction endonuclease mapping of unintegrated viral DNA of B- and N-tropic BALB/c murine leukemia virus. J Virol (1980) 1.58

Molecular cloning of viral DNA from leukemogenic Gross passage A murine leukemia virus and nucleotide sequence of its long terminal repeat. J Virol (1983) 1.55

Molecular cloning of B- and N-tropic endogenous BALB/c murine leukemia virus circular DNA intermediates: isolation and characterization of infectious recombinant clones. J Virol (1981) 1.52

Effect of Fv-1 gene product on synthesis of N-tropic and B-tropic murine leukemia viral RNA. Cell (1976) 1.50

Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene (1996) 1.45

Leukemogenicity of clonal isolates of murine leukemia viruses. J Natl Cancer Inst (1978) 1.44

Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice. Mol Cell Biol (2000) 1.42

The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J Virol (1991) 1.41

Maturation and subcellular compartmentation of potato starch phosphorylase. Plant Cell (1989) 1.39

Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax (2004) 1.38

Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell (1987) 1.35

Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax (2000) 1.33

Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol (1998) 1.30

An X-linked gene affecting mouse cell DNA synthesis also affects production of unintegrated linear and supercoiled DNA of murine leukemia virus. Mol Cell Biol (1984) 1.30

Visual search for colour targets that are or are not linearly separable from distractors. Vision Res (1996) 1.29

Spatial attention freezes during the attention blink. Psychophysiology (2006) 1.28

Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA. J Virol (1988) 1.27

Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene (2010) 1.25

Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J Virol (1998) 1.25

Endogenous mouse mammary tumor virus DNA is distributed among multiple mouse chromosomes. Virology (1979) 1.24

Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues. Mol Cell Biol (1989) 1.24

The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol (2001) 1.23

The time to name disoriented natural objects. Mem Cognit (1985) 1.20

Characterization of the gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome. J Virol (1990) 1.20

Relationship of impairment and functional ability to habitual activity and fitness following spinal cord injury. Int J Rehabil Res (1993) 1.19

Retrovirus-induced spongiform myeloencephalopathy in mice: regional distribution of infected target cells and neuronal loss occurring in the absence of viral expression in neurons. Proc Natl Acad Sci U S A (1991) 1.18

Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential. J Virol (1990) 1.16

The interdependence of spatial attention and lexical access as revealed by early asymmetries in occipito-parietal ERP activity. Psychophysiology (2007) 1.14

The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6. Immunity (2001) 1.14

Retrovirus-induced spongiform encephalopathy: the 3'-end long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome. Proc Natl Acad Sci U S A (1985) 1.12

Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. Biotechniques (1997) 1.11

Assessing the emetic potential of PDE4 inhibitors in rats. Br J Pharmacol (2002) 1.09

Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J Virol (1993) 1.09

The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome. Science (1991) 1.08

Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas. J Virol (1989) 1.08

Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J Exp Med (1998) 1.08

Specific expression of the human CD4 gene in mature CD4+ CD8- and immature CD4+ CD8+ T cells and in macrophages of transgenic mice. Mol Cell Biol (1994) 1.07

Identification of a new common provirus integration site in gross passage A murine leukemia virus-induced mouse thymoma DNA. Mol Cell Biol (1987) 1.06

Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma. J Virol (1987) 1.06

Studies on emerging radiation leukemia virus variants in C57BL/Ka mice. J Virol (1986) 1.05

Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil (1999) 1.05

Neurotropic Cas-BR-E murine leukemia virus harbors several determinants of leukemogenicity mapping in different regions of the genome. J Virol (1985) 1.04

Visual encoding of patterns is subject to dual-task interference. Mem Cognit (2000) 1.02

The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2. Oncogene (1993) 1.01

New adenovirus vectors for protein production and gene transfer. Cytotechnology (1998) 1.01

A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTV(D)/myc transgenic mice. Oncogene (1998) 1.01

Linkage results on 11Q21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. Am J Med Genet (1995) 1.00

Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J (1999) 1.00

Fate of unintegrated viral DNA in Fv-1 permissive and resistant mouse cells infected with murine leukemia virus. J Virol (1981) 1.00

Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells. J Virol (1994) 0.98

Susceptibility of inbred strains of mice to murine AIDS (MAIDS) correlates with target cell expansion and high expression of defective MAIDS virus. J Virol (1992) 0.97

Electrophysiological evidence of visual encoding deficits in a cross-modal attentional blink paradigm. Psychophysiology (2003) 0.96

The Myb and Ahi-1 genes are physically very closely linked on mouse chromosome 10. Mamm Genome (1994) 0.95

Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc Natl Acad Sci U S A (1993) 0.95

Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus. Virology (1997) 0.93

A viral long terminal repeat expressed in CD4+CD8+ precursors is downregulated in mature peripheral CD4-CD8+ or CD4+CD8- T cells. Mol Cell Biol (1992) 0.92

Identification of a novel gene, Vin-1, in murine leukemia virus-induced T-cell leukemias by provirus insertional mutagenesis. J Virol (1992) 0.92

Inability of Kaplan radiation leukemia virus to replicate on mouse fibroblasts is conferred by its long terminal repeat. J Virol (1988) 0.91

Detection of horses infected naturally with equine infectious anemia virus by nested polymerase chain reaction. J Virol Methods (2001) 0.91

Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus. J Virol (1997) 0.91

Mouse chromosomal mapping of a murine leukemia virus integration region (Mis-1) first identified in rat thymic leukemia. J Virol (1985) 0.91

Mouse hepatitis virus 3 replication in T and B lymphocytes correlate with viral pathogenicity. J Immunol (1989) 0.90

The combined effects of plane disorientation and foreshortening on picture naming: one manipulation or two? J Exp Psychol Hum Percept Perform (2000) 0.89

Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice. Oncogene (2006) 0.89